New York, NY -- (SBWIRE) -- 12/24/2013 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Sonus Networks, Inc (NASDAQ:SONS), Alpine Total Dynamic Dividend Fund (NYSE:AOD), Antares Pharma Inc (NASDAQ:ATRS), RadioShack Corporation (NYSE:RSH)
Sonus Networks, Inc (NASDAQ:SONS) showed a volume of 1.72 million shares by the end of last trade whereas the average volume of the stock remained 1.59 million shares. The stock opened the session at $3.16 but then moved to $3.17. At that price, the stock showed a positive performance of 3.59%. Sonus Networks, Inc. (Sonus) is a provider of networked solutions for communications service providers e.g., telecommunications, wireless and cable service providers and enterprises to help them advance, protect and unify their communications and improve collaboration. Its products include session border controllers, Session Initiation Protocol (SIP) session management servers, Voice over IP (VoIP) switches, SIP application servers, multiprotocol signaling gateways and network analytics tools. Its solutions address the need for communications service providers and enterprises to seamlessly link and leverage multivendor,
Will SONS Continue To Move Higher? Find Out Here
Alpine Total Dynamic Dividend Fund (NYSE:AOD) opened the session at $4.14and closed the session at $4.18. The stock showed a positive performance of 0.97% in previous trading session. Traded with volume 1.59 million shares in the prior session and the average volume of the stock remained 1.21 million shares. Alpine Total Dynamic Dividend Fund (the Fund) is a diversified, closed-end management investment company. The Fund’s investment objective is to seek high current dividend income. The Fund also focuses on long-term growth of capital as a secondary investment objective. It invests in various sectors, including consumer discretionary, industrials, energy, information technology, materials, consumer staples, healthcare, financials, utilities and telecommunication services. As of October 31, 2012, top 10 holdings of the Fund include Apple, Inc.,
For How Long AOD will fight for Profitability? Read This Trend Analysis report
Antares Pharma Inc (NASDAQ:ATRS) opened the session at $4.25 and closed the session at $4.25. The stock showed a positive performance of 0.24% in previous trading session. Traded with volume of 1.40 million shares in the prior session and the average volume of the stock remained 1.06 million shares. The beta of the stock remained 0.14. Antares Pharma, Inc. (Antares) is a pharma company that focuses on self-injection pharmaceutical products and technologies and topical gel-based products. The Company’s subcutaneous and intramuscular injection technology platforms include Vibex disposable pressure-assisted auto injectors, Vision reusable needle-free injectors, and disposable multi-use pen injectors. In the injector area, it has licensed its reusable needle-free injection device for use with human growth hormone (hGH) to Teva, Ferring Pharmaceuticals BV (Ferring) and JCR Pharmaceuticals Co., Ltd. (JCR),
Why Should Investors Buy ATRS After The Recent Gain? Just Go Here and Find Out
RadioShack Corporation (NYSE:RSH) the stock advanced 2.29% and finished the session at $2.68. Traded with volume of 1.29 million shares in the prior session and the average volume of the stock remained 1.75 million shares. The beta of the stock remained 1.53. RadioShack Corporation (RadioShack) is engaged in the retail sale of consumer electronics goods and services through its RadioShack store chain. The Company’ segments include U.S. Radioshack Company-Operated Stores and Others. As of December 31, 2012, the Company operated 4,395 U.S. company-operated stores under the RadioShack brand located throughout the United States, as well as in Puerto Rico and the U.S. Virgin Islands. These stores are located in strip centers and major shopping malls, as well as individual storefronts.
Will RSH Continue To Move Higher? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)